Akebia Therapeutics, Inc. (AKBA)

NASDAQ: AKBA · Real-Time Price · USD

0.9194

+0.0340 (3.84%)

At close: Aug 20, 2026, 4:00 PM EDT

0.9201

+0.0007 (0.08%)

After-hours: Aug 20, 2026, 5:24 PM EDT

Akebia Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	155.55	184.84	51.87	42.93	90.47	149.8
Cash & Short-Term Investments	155.55	184.84	51.87	42.93	90.47	149.8
Cash Growth	13.28%	256.36%	20.84%	-52.55%	-39.61%	-44.25%
Receivables	53.51	47.03	34.37	39.29	40.28	55.89
Inventory	13.02	15.61	16.24	15.69	21.57	36.63
Prepaid Expenses	-	-	4.03	14.49	15.62	28.83
Restricted Cash	1.71	1.7	-	-	-	-
Other Current Assets	5.77	3.77	7.32	5.75	17.25	-
Total Current Assets	229.55	252.96	113.83	118.15	185.18	271.15
Property, Plant & Equipment	7.31	4.89	10.42	16.05	34.37	40.61
Goodwill	59.04	59.04	59.04	59.04	59.04	59.04
Other Intangible Assets	-	-	-	36.04	72.08	108.13
Other Long-Term Assets	53.75	59.68	37.38	12.42	5.37	50.42
Total Assets	349.66	376.57	220.67	241.7	356.05	529.35

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	9.42	21.19	15.18	14.64	18.02	33.59
Accrued Expenses	89.65	92.13	33.27	42.94	53.92	97.51
Current Portion of Long-Term Debt	36.93	19.02	4.31	19.55	32	97.54
Current Portion of Leases	1.01	3.55	5.4	4.49	4.74	4.8
Current Unearned Revenue	6.17	2.68	-	-	3.74	20.91
Other Current Liabilities	17.69	24.38	22.75	18.26	17.12	6.7
Total Current Liabilities	160.87	162.94	80.91	99.87	129.54	261.05
Long-Term Debt	156.86	176.21	175.47	111.29	91.56	53.08
Long-Term Leases	4.4	-	3.55	8.95	28.96	33.7
Long-Term Unearned Revenue	-	-	-	43.3	43.3	21.47
Other Long-Term Liabilities	2.52	4.8	9.93	8.89	57.47	86.03
Total Liabilities	324.64	343.96	269.86	272.29	350.82	455.34

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	1,727	1,716	1,629	1,578	1,562	1,537
Retained Earnings	-1,702	-1,684	-1,678	-1,609	-1,557	-1,463
Comprehensive Income & Other	0.01	0.01	0.01	0.01	0.01	0.01
Shareholders' Equity	25.02	32.61	-49.19	-30.58	5.23	74.01
Total Liabilities & Equity	349.66	376.57	220.67	241.7	356.05	529.35

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	199.19	198.78	188.73	144.28	157.27	189.13
Net Cash (Debt)	-43.64	-13.94	-136.86	-101.35	-66.8	-39.33
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.16	-0.05	-0.65	-0.54	-0.37	-0.24
Filing Date Shares Outstanding	277.11	267.88	236.23	209.37	184.25	181.23
Total Common Shares Outstanding	271.74	265.42	224.85	194.58	184.14	177
Working Capital	68.69	90.02	32.92	18.28	55.65	10.1
Book Value Per Share	0.09	0.12	-0.22	-0.16	0.03	0.42
Tangible Book Value	-34.03	-26.43	-108.23	-125.67	-125.9	-93.16
Tangible Book Value Per Share	-0.13	-0.10	-0.48	-0.65	-0.68	-0.53
Machinery	-	-	-	-	-	5.85
Leasehold Improvements	-	-	-	-	-	8.57

SEC Filings: 10-K · 10-Q